Thursday, May 10, 2012
Cell Therapeutics' Pixuvri Approved in European Union as Monotherapy to Treat Adult Patients with Multiply Relapsed or Refractory Aggressive Non-Hodgkin B-Cell Lymphomas
(
CTIC
,
News
,
FDA
/ Thu, 02:31pm)
Friday, February 17, 2012
European Medicines Agency's Committee For Medicinal Products For Human Use Issues Positive Opinion For Conditional Approval On Marketing Authorization Application For Pixuvri™
(
CTIC
,
News
,
FDA
/ Fri, 08:36am)
Monday, January 30, 2012
Cell Therapeutics Plummeting on NDA Withdrawl
(
CTIC
,
News
,
FDA
,
Intraday Update
,
Movers
/ Mon, 10:52am)
From Earlier: Cell Therapeutics Withdraws New Drug Application for Pixuvri and Plans to Resubmit in 2012
(
CTIC
,
News
,
FDA
/ Mon, 07:46am)
Tuesday, January 03, 2012
From Earlier: Cell Therapeutic Announces FDA's Oncologic Drugs Advisory Committee to Review Resubmitted Pixantrone New Drug Application on February 9, 2012
(
CTIC
,
News
,
FDA
/ Tue, 08:16am)
Tuesday, December 13, 2011
Final OPAL Phase II Results of Tosedostat Demonstrate Significant Response Rates in Elderly Patients with Treatment Refractory or Relapsed Primary or Secondary Acute Myeloid Leukemia
(
CTIC
,
News
,
FDA
/ Tue, 08:26am)
Tuesday, October 25, 2011
Cell Therapeutics Resubmits Pixantrone NDA to FDA for Consideration of Accelerated Approval
(
CTIC
,
News
,
FDA
/ Tue, 06:27am)
Tuesday, August 23, 2011
Cell Therapeutics Submits Day 120 Response for Pixantrone Marketing Authorization Application to European Medicines Agency
(
CTIC
,
News
,
FDA
/ Tue, 06:49am)
Thursday, August 18, 2011
Randomized Study Comparing Cell Therapeutics' OPAXIO and Radiotherapy to Standard of Care Temozolomide and Radiotherapy Treatment Open for Enrollment
(
CTIC
,
News
,
FDA
/ Thu, 06:51am)
Friday, June 17, 2011
Pixantrone in Combination with Others Produces High Rates of Complete Remissions in Patients with Relapsed or Refractory Indolent Non-Hodgkins Lymphoma
(
CTIC
,
News
,
FDA
/ Fri, 08:06am)
Tuesday, June 14, 2011
Cell Therapeutics Completes Type A Meeting With FDA's Division of Oncology Drug Products: Guidance Provided for Resubmission of Pixantrone NDA for Consideration of Accelerated Approval
(
CTIC
,
News
,
FDA
/ Tue, 06:56am)
Friday, March 11, 2011
Cell Therapeutics Rises 40% (CTIC)
(
CTIC
,
News
,
FDA
,
Intraday Update
,
Movers
/ Fri, 05:31pm)
Thursday, June 03, 2010
Axia Slashes Estimates for Cell Therapeutics (CTIC)
(
Analyst Color
,
CTIC
,
News
,
FDA
,
Intraday Update
,
Analyst Ratings
/ Thu, 03:20pm)
Monday, March 22, 2010
Cell Therapeutics Down 50% After Trading Re-Opens (CTIC)
(
CTIC
,
FDA
,
Intraday Update
,
Movers
/ Mon, 01:59pm)
Thursday, March 04, 2010
Cell Therapeutics Higher After Review Rescheduled (CTIC)
(
CTIC
,
News
,
FDA
,
Markets
,
Movers
/ Thu, 03:38pm)
Monday, March 01, 2010
Cell Therapeutics Takes a Dive
(
CTIC
,
Options
,
FDA
,
Trading Ideas
/ Mon, 10:52am)